头孢特仑新戊酯在儿科的临床研究
[Clinical studies on cefteram pivoxil in pediatrics].
作者信息
Yokoyama M, Yonesaka S, Aoyama R, Sudou Y
机构信息
Department of Pediatrics, School of Medicine, Hirosaki University.
出版信息
Jpn J Antibiot. 1989 Aug;42(8):1745-50.
PMID:2810738
Abstract
Cefteram pivoxil (CFTM-PI), a newly developed oral cephem antibiotic was administered to treat 16 children with various infections. The results were summarized as follows. 1. The clinical responses were "excellent" in 7, "good" in 5, "fair" in 3 and "poor" in 1, with 75.0% efficacy rate. 2. No side effects and no abnormal laboratory findings were observed.
摘要
头孢特仑新戊酯（CFTM-PI），一种新开发的口服头孢菌素类抗生素，被用于治疗16名患有各种感染的儿童。结果总结如下。1. 临床反应为“优秀”的有7例，“良好”的有5例，“中等”的有3例，“差”的有1例，有效率为75.0%。2. 未观察到副作用和实验室检查异常。
Zotero 插件